Investors / Israel / Xenia Venture Capital
Xenia Venture Capital
Venture capital · Tel Aviv, Israel · Middle East and Africa
Xenia Venture Capital is an investment company that invests mainly in life science companies in Israel. It also holds 50% of VLX, a technological incubator operating under the Israel Innovation Authority incubator program, and provides portfolio companies with mentoring, business and strategic counseling, fundraising assistance and exit planning.
Invests inHealthcare & Biotech
In its own wordslife scienceshealthcaremedical devicesincubatorisrael
Your fit with Xenia Venture Capital
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsXenia Venture Capital lists 2 checked portfolio companies on its own site. Its largest theme is Healthcare & Biotech (100%). 100% of its companies are based in United States. It invests most often alongside Investisseurs & Partenaires, MVM Partners and Peregrine Ventures.
No funding round on record names Xenia Venture Capital yet, so the figures come from its portfolio page.
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| Investisseurs & Partenaires | 1 |
| MVM Partners | 1 |
| Peregrine Ventures | 1 |
| Precede Technologies | 1 |
| Regah Ventures | 1 |
| Triventures | 1 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers2100%
- No longer answers00%
- Points to another company00%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 100% | 15% |
Co-investor network
who it backs companies with, and who they back togetherAll co-investors or Compare portfolios with Investisseurs & Partenaires
Compare Xenia Venture Capital head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Portfolio
2 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| The company develops a balloon implant system used to protect healthy tissue from radiation during oncology treatments. | Healthcare & Biotech | Portfolio page | ||
| PolyPid develops long-acting, controlled-release medicines for surgical care, metabolic diseases, and other areas. | Healthcare & Biotech | Portfolio page |
About this data
site last read 5 Nov 2026- Site
- xenia.co.il
- Last read
- 5 Nov 2026
- Watching since
- 5 Nov 2026
- Companies checked
- 2
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Xenia Venture Capital's profile as data
Pull Xenia Venture Capital's portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/xenia.co.il
# also
GET /v1/firms/xenia.co.il/portfolio
GET /v1/firms/xenia.co.il/coinvestors
GET /v1/firms/xenia.co.il/news